Belgium -
English -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
rasagiline krka 1 mg tabl.
krka d.d. novo mesto d.d. - rasagiline mesylate 1,44 mg - eq. rasagiline 1 mg - tablet - 1 mg - rasagiline mesilate 1.44 mg - rasagiline
Belgium -
English -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
rasagiline teva 1 mg tabl.
teva pharma belgium sa-nv - rasagiline mesylate 1,56 mg - eq. rasagiline 1 mg - tablet - 1 mg - rasagiline mesilate 1.56 mg - rasagiline
United Kingdom -
English -
myHealthbox
rasagiline 1mg tablets
caduceus pharma ltd - rasagiline - tablets - 1mg - anti-parkinson-drugs, monoamine oxidase -b inhibitors - it is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
dr reddy's laboratories (uk - rasagiline - tablet - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
a a h pharmaceuticals ltd - rasagiline - tablet - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
hbs healthcare ltd - rasagiline - tablet - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
accord healthcare ltd - rasagiline - tablet - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
rivopharm (uk - rasagiline - tablet - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
milpharm ltd - rasagiline - tablet - 1mg
Australia -
English -
Department of Health (Therapeutic Goods Administration)
rasalect rasagiline (as mesilate) 1 mg tablet blister pack
teva pharma australia pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: stearic acid; purified talc; mannitol; colloidal anhydrous silica; maize starch; pregelatinised maize starch - rasalect is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.